Literature DB >> 15231629

Open letter to Annette King, Minister of Health, New Zealand.

Andrew Herxheimer.   

Abstract

Mesh:

Year:  2004        PMID: 15231629      PMCID: PMC443459          DOI: 10.1136/bmj.329.7456.51

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Counting the costs of drug-related adverse events.

Authors:  T J White; A Arakelian; J P Rho
Journal:  Pharmacoeconomics       Date:  1999-05       Impact factor: 4.981

2.  Mianserin and agranulocytosis in New Zealand.

Authors:  D M Coulter; I R Edwards
Journal:  Lancet       Date:  1990-09-29       Impact factor: 79.321

3.  Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

Authors:  J Lazarou; B H Pomeranz; P N Corey
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

4.  The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group.

Authors:  D W Bates; N Spell; D J Cullen; E Burdick; N Laird; L A Petersen; S D Small; B J Sweitzer; L L Leape
Journal:  JAMA       Date:  1997 Jan 22-29       Impact factor: 56.272

  4 in total
  3 in total

1.  Open letter to Annette King, Minister of Health, New Zealand: intensive medicines monitoring programme is not due to be stopped.

Authors:  Don Matheson
Journal:  BMJ       Date:  2004-08-21

2.  Open letter to Annette King, Minister of Health, New Zealand: Official response is misleading.

Authors:  David Coulter
Journal:  BMJ       Date:  2004-08-21

3.  Who will fund hypothesis testing studies?

Authors:  Mira Harrison-Woolrych
Journal:  BMJ       Date:  2006-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.